PSEN1 and Alzheimer disease: In addition, double transgenic APP/PS1 mice injected with bone-MSCs can activate the sphingosine kinase-1/sphingosine-1-phosphate signaling pathway to reduce Aβ deposition and promote cognitive function recovery in AD mice (Wang and Yang, 2021).